+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD ), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 130 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 4452077
The global drug of abuse testing services market size is expected to reach USD 8.54 billion by 2030, expanding at a CAGR of 3.91% from 2023 to 2030. The presence of a developed laboratory network and the prevalence of addiction are key drivers for market growth. Furthermore, the increasing trend of different drug use in the community and the importance of testing for the detection of illicit drugs and alcohol is expected to drive the demand. Thereby, continued test offering across the globe has fueled the growth.

Additionally, rising psychiatric disorders patients and hospitalizations due to the consumption of the drugs have boosted the demand. For instance, January 2023, National Survey on Drug Use and Health Results Detailing Mental Illness & Substance Use Levels (2021) was announced by SAMHSA. The survey mentioned that 16.5% of the aged 12 or older population (or 46.3 million) people had a substance use disorder wherein 29.5 million people were classified to have alcohol use disorder & 24 million people had drug use disorder.

In addition, the growing awareness among the population and the unmet need for treatment of addiction and illicit medication use among youth and adults is projected to boost the demand for the drug of abuse testing services industry. For instance, in August 2020, Averhealth announced the acquisition of the drug testing services of the Treatment Assessment Screening Center in Arizona. Therefore, increasing the focus of players to minimize the burden of addiction in emerging countries propels the market revenue. This factor has led companies to develop innovative and effective services for abuse cases.

Likewise, the COVID-19 pandemic has moderately impacted the market. During the pandemic, a constant demand for detection services was attributable to the increased addiction to Cannabis/Marijuana and opioids among the youth and adult population. According to United Nations Office on Drugs and Crime (UNODC), in 2020, around 275 million people used drugs worldwide, while according to the 2021 World Drug Report, over 36 million population suffered from drug use disorders. This factor has led to rising requirements for services post-pandemic.

Furthermore, the key participants are engaged in strategies such as agreements, mergers & acquisitions, partnerships, and launches, among others, to expand their global footprints and product portfolio. For instance, in December 2022, Urine Drugs of Abuse testing services was launched by Omega Laboratories in Canada. Adding to that from January 2023, the laboratory will offer urine testing to complement its molecular testing. The expansion of toxicology services will offer consumers an alternative to limited options available in Canada.

Drug Of Abuse Testing Services Market Report Highlights

  • Cannabis/Marijuana segment held the largest revenue share of the market in 2022 and is anticipated to grow at the fastest growth rate over the forecast period owing to the prevalence of cannabis/marijuana addiction, demand for medical screening, and employment testing drives the growth
  • North America held the largest share of the market in 2022. The presence of well-established market players, demand for various addiction treatments, growing consumption, and addiction to cannabis/marijuana among youth drive regional growth
  • Key players operating in the drug of abuse testing services constantly focus on product launches and geographical expansion to maintain their presence

Table of Contents

Chapter 1. Drug of Abuse Testing Services Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Drug Type Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Drug of Abuse Testing Services Market: Executive Summary
2.1. Market Snapshot
2.2. Drug Type Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Drug of Abuse Testing Services Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. High prevalence of substance abuse & growing demand for its treatment
3.4.2. Increase in government initiatives to monitor substance abuse
3.4.3. Stringent law mandating alcohol and drug testing
3.5. Market Restraint Analysis
3.5.1. Drug testing is considered a violation of privacy rights in some countries
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. Drug of Abuse Testing Services Market: Drug Type Estimates & Trend Analysis
4.1. Drug of Abuse Testing Services Market: Drug Type Movement Analysis
4.2. Alcohol
4.2.1. Alcohol Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3. Cannabis/Marijuana
4.3.1. Cannabis/Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cocaine
4.4.1. Cocaine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Opioids
4.5.1. Opioids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Amphetamine & Methamphetamine
4.6.1. Amphetamine & Methamphetamine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. LSD
4.7.1. LSD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Drug of Abuse Testing Services Market: Regional Business Analysis
5.1. Regional Market Snapshot
5.2. North America
5.2.1. North America Drug of Abuse Testing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.2.2.2. Key Country Dynamics
5.2.2.3. Regulatory Framework
5.2.2.4. Reimbursement Scenario
5.2.2.5. Competitive Scenario
5.2.3. Canada
5.2.3.1. Canada Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.2.3.2. Key Country Dynamics
5.2.3.3. Regulatory Framework
5.2.3.4. Reimbursement Scenario
5.2.3.5. Competitive Scenario
5.3. Europe
5.3.1. Europe Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.2. Germany
5.3.2.1. Germany Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.2.2. Key Country Dynamics
5.3.2.3. Regulatory Framework
5.3.2.4. Reimbursement Scenario
5.3.2.5. Competitive Scenario
5.3.3. UK
5.3.3.1. UK Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.3.2. Key Country Dynamics
5.3.3.3. Regulatory Framework
5.3.3.4. Reimbursement Scenario
5.3.3.5. Competitive Scenario
5.3.4. France
5.3.4.1. France Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.4.2. Key Country Dynamics
5.3.4.3. Regulatory Framework
5.3.4.4. Reimbursement Scenario
5.3.4.5. Competitive Scenario
5.3.5. Spain
5.3.5.1. Spain Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.5.2. Key Country Dynamics
5.3.5.3. Regulatory Framework
5.3.5.4. Reimbursement Scenario
5.3.5.5. Competitive Scenario
5.3.6. Italy
5.3.6.1. Italy Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.6.2. Key Country Dynamics
5.3.6.3. Regulatory Framework
5.3.6.4. Reimbursement Scenario
5.3.6.5. Competitive Scenario
5.3.7. Denmark
5.3.7.1. Denmark Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.7.2. Key Country Dynamics
5.3.7.3. Regulatory Framework
5.3.7.4. Reimbursement Scenario
5.3.7.5. Competitive Scenario
5.3.8. Norway
5.3.8.1. Norway Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.8.2. Key Country Dynamics
5.3.8.3. Regulatory Framework
5.3.8.4. Reimbursement Scenario
5.3.8.5. Competitive Scenario
5.3.9. Sweden
5.3.9.1. Sweden Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.9.2. Key Country Dynamics
5.3.9.3. Regulatory Framework
5.3.9.4. Reimbursement Scenario
5.3.9.5. Competitive Scenario
5.4. Asia Pacific
5.4.1. Asia-Pacific Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.2. Japan
5.4.2.1. Japan Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.2.2. Key Country Dynamics
5.4.2.3. Regulatory Framework
5.4.2.4. Reimbursement Scenario
5.4.2.5. Competitive Scenario
5.4.3. China
5.4.3.1. China Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.3.2. Key Country Dynamics
5.4.3.3. Regulatory Framework
5.4.3.4. Reimbursement Scenario
5.4.3.5. Competitive Scenario
5.4.4. India
5.4.4.1. India Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.4.2. Key Country Dynamics
5.4.4.3. Regulatory Framework
5.4.4.4. Reimbursement Scenario
5.4.4.5. Competitive Scenario
5.4.5. Australia
5.4.5.1. Australia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.5.2. Key Country Dynamics
5.4.5.3. Regulatory Framework
5.4.5.4. Reimbursement Scenario
5.4.5.5. Competitive Scenario
5.4.6. South Korea
5.4.6.1. South Korea Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.6.2. Key Country Dynamics
5.4.6.3. Regulatory Framework
5.4.6.4. Reimbursement Scenario
5.4.6.5. Competitive Scenario
5.4.7. Thailand
5.4.7.1. Thailand Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.7.2. Key Country Dynamics
5.4.7.3. Regulatory Framework
5.4.7.4. Reimbursement Scenario
5.4.7.5. Competitive Scenario
5.5. Latin America
5.5.1. Latin America Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.2.2. Key Country Dynamics
5.5.2.3. Regulatory Framework
5.5.2.4. Reimbursement Scenario
5.5.2.5. Competitive Scenario
5.5.3. Mexico
5.5.3.1. Mexico Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.3.2. Key Country Dynamics
5.5.3.3. Regulatory Framework
5.5.3.4. Reimbursement Scenario
5.5.3.5. Competitive Scenario
5.5.4. Argentina
5.5.4.1. Argentina Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.4.2. Key Country Dynamics
5.5.4.3. Regulatory Framework
5.5.4.4. Reimbursement Scenario
5.5.4.5. Competitive Scenario
5.6. MEA
5.6.1. MEA Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.2.2. Key Country Dynamics
5.6.2.3. Regulatory Framework
5.6.2.4. Reimbursement Scenario
5.6.2.5. Competitive Scenario
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.3.2. Key Country Dynamics
5.6.3.3. Regulatory Framework
5.6.3.4. Reimbursement Scenario
5.6.3.5. Competitive Scenario
5.6.4. UAE
5.6.4.1. UAE Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.4.2. Key Country Dynamics
5.6.4.3. Regulatory Framework
5.6.4.4. Reimbursement Scenario
5.6.4.5. Competitive Scenario
5.6.5. Kuwait
5.6.5.1. Kuwait Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.5.2. Key Country Dynamics
5.6.5.3. Regulatory Framework
5.6.5.4. Reimbursement Scenario
5.6.5.5. Competitive Scenario
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.2.1. New Launch
6.2.2. Partnerships
6.2.3. Acquisition
6.2.4. Collaboration
6.3. Key Company Market Share Analysis, 2022
6.4. Company Heat Map Analysis
6.5. Company Profiles
6.5.1. QUEST DIAGNOSTICS
6.5.1.1. Company Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. ABBOTT
6.5.2.1. Company Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. CLINICAL REFERENCE LABORATORY (CRL), INC.
6.5.3.1. Company Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. LABORATORY CORPORATION OF AMERICA HOLDINGS
6.5.4.1. Company Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. CORDANT HEALTH SOLUTIONS
6.5.5.1. Company Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives
6.5.6. LEGACY MEDICAL SERVICES
6.5.6.1. Company Overview
6.5.6.2. Financial Performance
6.5.6.3. Product Benchmarking
6.5.6.4. Strategic Initiatives
6.5.7. DRUGSCAN
6.5.7.1. Company Overview
6.5.7.2. Financial Performance
6.5.7.3. Product Benchmarking
6.5.7.4. Strategic Initiatives
6.5.8. OMEGA LABORATORIES, INC.
6.5.8.1. Company Overview
6.5.8.2. Financial Performance
6.5.8.3. Product Benchmarking
6.5.8.4. Strategic Initiatives
6.5.9. PSYCHEMEDICS CORPORATION
6.5.9.1. Company Overview
6.5.9.2. Financial Performance
6.5.9.3. Product Benchmarking
6.5.9.4. Strategic Initiatives
6.5.10. MILLENNIUM HEALTH, LLC
6.5.10.1. Company Overview
6.5.10.2. Financial Performance
6.5.10.3. Product Benchmarking
6.5.10.4. Strategic Initiatives
6.5.11. MAYO CLINIC LABORATORIES
6.5.11.1. Company Overview
6.5.11.2. Financial Performance
6.5.11.3. Product Benchmarking
6.5.11.4. Strategic Initiatives
6.5.12. PRECISION DIAGNOSTICS
6.5.12.1. Company Overview
6.5.12.2. Financial Performance
6.5.12.3. Product Benchmarking
6.5.12.4. Strategic Initiatives
6.5.13. AMERICAN SUBSTANCE ABUSE PROFESSIONALS (ASAP), INC.
6.5.13.1. Company Overview
6.5.13.2. Financial Performance
6.5.13.3. Product Benchmarking
6.5.13.4. Strategic Initiatives
6.5.14. UNITED STATES DRUG TESTING LABORATORIES (USDTL), INC.
6.5.14.1. Company Overview
6.5.14.2. Financial Performance
6.5.14.3. Product Benchmarking
6.5.14.4. Strategic Initiatives
6.5.15. LGC GROUP
6.5.15.1. Company Overview
6.5.15.2. Financial Performance
6.5.15.3. Product Benchmarking
6.5.15.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Drug of Abuse Testing Services Market, By Region, 2018 - 2030 (USD Million)
Table 4 North America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 5 North America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 6 U.S. Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 7 Canada Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 8 Europe Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 9 Europe Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 10 Germany Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 11 UK Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 12 France Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 13 Spain Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 14 Italy Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 15 Denmark Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 16 Norway Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 17 Sweden Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 18 Asia Pacific Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 19 Asia Pacific Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 20 Japan Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 21 China Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 22 India Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 23 Australia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 24 South Korea Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 25 Thailand Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 26 Latin America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 27 Latin America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 28 Brazil Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 29 Mexico Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 30 Argentina Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 31 Middle East & Africa Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 32 Middle East & Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 33 Saudi Arabia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 34 South Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 35 UAE Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 36 Kuwait Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global drug of abuse testing services market - Key market driver analysis
Fig. 7 Global drug of abuse testing services market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global drug of abuse testing services market - Porter’s analysis
Fig. 10 Global drug of abuse testing services market - PESTEL analysis
Fig. 11 Global drug of abuse testing services market drug type outlook key takeaways
Fig. 12 Global drug of abuse testing services market: Drug type movement analysis
Fig. 13 Alcohol market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Cannabis/Marijuana market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Cocaine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Opioids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Amphetamine & Methamphetamine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 LSD market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Regional marketplace: Key takeaways
Fig. 21 Global drug of abuse testing services market: Regional movement analysis
Fig. 22 North America drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 23 U.S. drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 24 Canada drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 25 Europe drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 26 Germany drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 27 UK drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 28 France drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 29 Spain drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 30 Italy drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 31 Denmark drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 32 Norway drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 33 Sweden drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 34 Asia Pacific drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 35 Japan drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 36 China drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 37 India drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 38 Australia drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 39 South Korea drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 40 Thailand drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 41 Latin America drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 42 Brazil drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 43 Mexico drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 44 Argentina drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 45 MEA drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 46 South Africa drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 47 Saudi Arabia drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 48 UAE drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 49 Kuwait drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 50 Strategy framework

Companies Mentioned

  • QUEST DIAGNOSTICS
  • ABBOTT
  • CLINICAL REFERENCE LABORATORY (CRL), INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • CORDANT HEALTH SOLUTIONS
  • LEGACY MEDICAL SERVICES
  • DRUGSCAN
  • OMEGA LABORATORIES, INC.
  • PSYCHEMEDICS CORPORATION
  • MILLENNIUM HEALTH, LLC
  • MAYO CLINIC LABORATORIES
  • PRECISION DIAGNOSTICS
  • AMERICAN SUBSTANCE ABUSE PROFESSIONALS (ASAP), INC.
  • UNITED STATES DRUG TESTING LABORATORIES (USDTL), INC.
  • LGC GROUP

Methodology

Loading
LOADING...

Table Information